New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd.
Patent applicants often file provisional applications at the United States Patent and Trademark Office (USPTO) to secure a priority date before filing a full-blown utility patent application for their ...
CUMBERLAND, Md., May 01, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of Cannabinoids in the research, development, and commercialization of life ...
In a decision issued today, the Federal Circuit addressed the issue of whether an Examiner can rely on the filing date of a provisional application under pre-AIA 102(e) to support a rejection based on ...
“Before filing, every inventor should pause and ask these seven questions. Doing so doesn’t just improve your odds of getting a patent granted, but it also strengthens your ability to enforce, license ...
“Unfortunately, the additional fees may induce a chilling effect on filing continuing applications. [But] by understanding the new fee structure and adjusting their filing practices accordingly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback